Andrew Leuchter
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Area:
Neurobiology Biology, Radiology, Mental HealthGoogle:
"Andrew Leuchter"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Slan AR, Citrenbaum C, Corlier J, et al. (2024) The role of sex and age in the differential efficacy of 10 Hz and intermittent Theta-burst (iTBS) repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD). Journal of Affective Disorders |
| Leuchter MK, Citrenbaum C, Wilson AC, et al. (2024) The effect of older age on outcomes of rTMS treatment for treatment-resistant depression. International Psychogeriatrics. 1-6 |
| Berman ZR, Citrenbaum C, Corlier J, et al. (2024) Sequential Multilocus Repetitive Transcranial Magnetic Stimulation for Treatment of Tinnitus With and Without Comorbid Major Depressive Disorder. Neuromodulation : Journal of the International Neuromodulation Society |
| Leuchter MK, Citrenbaum C, Wilson AC, et al. (2023) A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression. Psychiatry Research. 330: 115608 |
| Citrenbaum C, Corlier J, Ngo D, et al. (2023) Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD). Brain Stimulation |
| Tadayonnejad R, Citrenbaum C, Ngo TDP, et al. (2023) Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression. Brain Stimulation. 16: 1374-1376 |
| Chu SA, Tadayonnejad R, Corlier J, et al. (2023) Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment. Translational Psychiatry. 13: 293 |
| Citrenbaum C, Corlier J, Ngo D, et al. (2023) Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Journal of Affective Disorders |
| Tadayonnejad R, Wilson AC, Chu SA, et al. (2022) Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder. Psychiatry Research. 317: 114856 |
| Wilke SA, Johnson CL, Corlier J, et al. (2022) Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder. Depression and Anxiety |